Severe intestinal vasculitis in a patient under treatment with bortezomib

Annals of Hematology

Volumn 86, Issue 12, 2007, Pages 923-924

  Mangiacavalli, Silvia ^a   Zappasodi, Patrizia ^a   Castagnola, Carlo ^a   Astori, Cesare ^a   Varettoni, Marzia ^a   Lazzarino, Mario ^a   Corso, Alessandro ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; BORTEZOMIB; DEXAMETHASONE; PYRAZINE DERIVATIVE;

ALLERGIC VASCULITIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; ENTEROPATHY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LETTER; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE MYELOMA; POSTOPERATIVE COMPLICATION; SALVAGE THERAPY;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BORONIC ACIDS; COMBINED MODALITY THERAPY; DEXAMETHASONE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTESTINAL DISEASES; MIDDLE AGED; MULTIPLE MYELOMA; POSTOPERATIVE COMPLICATIONS; PYRAZINES; SALVAGE THERAPY; VASCULITIS, ALLERGIC CUTANEOUS; VASCULITIS, HYPERSENSITIVITY;

EID: 40949113808     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-007-0334-2     Document Type: Letter

References (10)

1. Richardson PG, Barlogie B, Berenson J et al (2003) A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 348:2609-2617
2. Jagannath S, Barlogie B, Berenson J et al (2004) A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol 127:165-172
3. Richardson PG, Sonneveld P, Schuster MW et al (2005) Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 352:2487-2498
4. Agterof MJ, Biesma DH (2005) Bortezomib-induced skin lesions. N Engl J Med 352:2534
5. Varettoni M, Vassallo C, Borroni G et al (2006) Late onset of bortezomib-associated cutaneous reaction following herpes zoster. Ann Hematol 86:301-302
6. Collins WJ, Bending DW, Taylor WF (1979) Pulmonary vasculitis complicating childhood ulcerative colitis. Gastroenterology 77:1091-1093
7. Lawrence T, Gilroy DW, Colville-Nash PR et al (2001) Possible role for NF-κB in the resolution of inflammation. Nat Med 7:1291-1297
8. Sun K, Welniak LA, Panoskaltis-Mortari A et al (2004) Inhibition of acute graft-versus-host disease with retention of graftversus-tumor effect by proteasome inhibitor bortezomib. Proc Natl Acad Sci U S A 101:8120-8125
9. Sun K, Wilkins DE, Anver MR et al (2005) Differential effects of proteasome inhibition by bortezomib on murine acute graftversus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity. Blood 106:3293-3299
10. Uy GL, Holt MS, Fisher NM et al (2005) Bortezomib alters peripheral blood lymphocyte subsets in patients with multiple myeloma. Blood 106:672 (abstr)